Safety and clinical efficacy of AGT-181, a brain penetrating human insulin receptor antibody-iduronidase fusion protein, in a 26-week study with pediatric patients with mucopolysaccharidosis type I. Giugliani, R., Giugliani, L., Corte, A., D., Poswar, F., Donis, K., Schmidt, M., Hunt, D., Boado, R., J., & Pardridge, W., M. Molecular Genetics and Metabolism, 123(2):S54, 2, 2018. Website doi bibtex @article{
title = {Safety and clinical efficacy of AGT-181, a brain penetrating human insulin receptor antibody-iduronidase fusion protein, in a 26-week study with pediatric patients with mucopolysaccharidosis type I},
type = {article},
year = {2018},
pages = {S54},
volume = {123},
websites = {https://linkinghub.elsevier.com/retrieve/pii/S1096719217309034},
month = {2},
id = {bc31d112-1137-36da-8d9c-d6b5f95eb336},
created = {2020-02-15T13:15:24.728Z},
file_attached = {false},
profile_id = {a1b2ded6-b257-3e56-ac7c-9d438762d170},
last_modified = {2021-10-19T17:30:55.232Z},
read = {false},
starred = {false},
authored = {true},
confirmed = {true},
hidden = {false},
private_publication = {false},
bibtype = {article},
author = {Giugliani, Roberto and Giugliani, Luciana and Corte, Amauri Dalla and Poswar, Fabiano and Donis, Karina and Schmidt, Mathias and Hunt, Douglas and Boado, Ruben J. and Pardridge, William M.},
doi = {10.1016/j.ymgme.2017.12.128},
journal = {Molecular Genetics and Metabolism},
number = {2}
}
Downloads: 0
{"_id":"bYSHFfcWweuTBsssr","bibbaseid":"giugliani-giugliani-corte-poswar-donis-schmidt-hunt-boado-etal-safetyandclinicalefficacyofagt181abrainpenetratinghumaninsulinreceptorantibodyiduronidasefusionproteinina26weekstudywithpediatricpatientswithmucopolysaccharidosistypei-2018","authorIDs":[],"author_short":["Giugliani, R.","Giugliani, L.","Corte, A., D.","Poswar, F.","Donis, K.","Schmidt, M.","Hunt, D.","Boado, R., J.","Pardridge, W., M."],"bibdata":{"title":"Safety and clinical efficacy of AGT-181, a brain penetrating human insulin receptor antibody-iduronidase fusion protein, in a 26-week study with pediatric patients with mucopolysaccharidosis type I","type":"article","year":"2018","pages":"S54","volume":"123","websites":"https://linkinghub.elsevier.com/retrieve/pii/S1096719217309034","month":"2","id":"bc31d112-1137-36da-8d9c-d6b5f95eb336","created":"2020-02-15T13:15:24.728Z","file_attached":false,"profile_id":"a1b2ded6-b257-3e56-ac7c-9d438762d170","last_modified":"2021-10-19T17:30:55.232Z","read":false,"starred":false,"authored":"true","confirmed":"true","hidden":false,"private_publication":false,"bibtype":"article","author":"Giugliani, Roberto and Giugliani, Luciana and Corte, Amauri Dalla and Poswar, Fabiano and Donis, Karina and Schmidt, Mathias and Hunt, Douglas and Boado, Ruben J. and Pardridge, William M.","doi":"10.1016/j.ymgme.2017.12.128","journal":"Molecular Genetics and Metabolism","number":"2","bibtex":"@article{\n title = {Safety and clinical efficacy of AGT-181, a brain penetrating human insulin receptor antibody-iduronidase fusion protein, in a 26-week study with pediatric patients with mucopolysaccharidosis type I},\n type = {article},\n year = {2018},\n pages = {S54},\n volume = {123},\n websites = {https://linkinghub.elsevier.com/retrieve/pii/S1096719217309034},\n month = {2},\n id = {bc31d112-1137-36da-8d9c-d6b5f95eb336},\n created = {2020-02-15T13:15:24.728Z},\n file_attached = {false},\n profile_id = {a1b2ded6-b257-3e56-ac7c-9d438762d170},\n last_modified = {2021-10-19T17:30:55.232Z},\n read = {false},\n starred = {false},\n authored = {true},\n confirmed = {true},\n hidden = {false},\n private_publication = {false},\n bibtype = {article},\n author = {Giugliani, Roberto and Giugliani, Luciana and Corte, Amauri Dalla and Poswar, Fabiano and Donis, Karina and Schmidt, Mathias and Hunt, Douglas and Boado, Ruben J. and Pardridge, William M.},\n doi = {10.1016/j.ymgme.2017.12.128},\n journal = {Molecular Genetics and Metabolism},\n number = {2}\n}","author_short":["Giugliani, R.","Giugliani, L.","Corte, A., D.","Poswar, F.","Donis, K.","Schmidt, M.","Hunt, D.","Boado, R., J.","Pardridge, W., M."],"urls":{"Website":"https://linkinghub.elsevier.com/retrieve/pii/S1096719217309034"},"biburl":"https://bibbase.org/service/mendeley/a1b2ded6-b257-3e56-ac7c-9d438762d170","bibbaseid":"giugliani-giugliani-corte-poswar-donis-schmidt-hunt-boado-etal-safetyandclinicalefficacyofagt181abrainpenetratinghumaninsulinreceptorantibodyiduronidasefusionproteinina26weekstudywithpediatricpatientswithmucopolysaccharidosistypei-2018","role":"author","metadata":{"authorlinks":{}},"downloads":0},"bibtype":"article","creationDate":"2020-02-15T13:16:38.872Z","downloads":0,"keywords":[],"search_terms":["safety","clinical","efficacy","agt","181","brain","penetrating","human","insulin","receptor","antibody","iduronidase","fusion","protein","week","study","pediatric","patients","mucopolysaccharidosis","type","giugliani","giugliani","corte","poswar","donis","schmidt","hunt","boado","pardridge"],"title":"Safety and clinical efficacy of AGT-181, a brain penetrating human insulin receptor antibody-iduronidase fusion protein, in a 26-week study with pediatric patients with mucopolysaccharidosis type I","year":2018,"biburl":"https://bibbase.org/service/mendeley/a1b2ded6-b257-3e56-ac7c-9d438762d170","dataSources":["KeLrgK49soyCLiQgv","ya2CyA73rpZseyrZ8","2252seNhipfTmjEBQ"]}